Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in ABUS — Arbutus Biopharma Corp

CIK 1387508 NEW YORK, NY

Position in ABUS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$113,931
-$7,848 QoQ
Shares Held
25,318
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ABUS Over Time

Shares Held

Position Value (USD)

Derivatives in ABUS

reported options exposure · as of Dec 31, 2020
CallValue
$0
CallShares
0
PutValue
$160,815
PutShares
45,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ABUS

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $113,931 25,318
2025-12-31 $121,779 25,318
2025-09-30 $114,943 25,318
2025-06-30 $78,232 25,318
2023-06-30 $43,217 18,790
2023-03-31 $94,532 31,199
2022-12-31 $93,547 40,149
2022-09-30 $102,905 53,877
2022-06-30 $185,811 68,565
2022-03-31 $177,310 59,500
2021-12-31 $172,327 44,300
2021-09-30 $167,310 39,000
2020-12-31 $160,105 45,100
2020-12-31 $160,815 45,300
2020-09-30 $140,850 45,000
2020-09-30 $140,850 45,000